Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSBabyBiome: Timing of Cord Clamping and Neonatal Microbiome
NCT06030713Completed
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2019
- Primary completion
- Oct 2022
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Randomised, open-label trial of cefazolin in surgical site infection (SSI) (2 arms), sponsored by University Medical Center Groningen. Primary endpoints: Infant microbial species level differences at 6 weeks, Infant Alpha Diversity at 6 weeks and 2 more. Started Mar 2019; status: completed.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT06030713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06030713.